Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Yip1 domain family member 6 (YIPF6) is a transmembrane protein found in the ER and Golgi apparatus, with five membrane-spanning domains and a cytoplasmic N-terminal domain. YIPF6 forms complexes with other YIPF proteins (YIPF1, YIPF2) for Golgi function and glycan synthesis, and is essential for the normal secretion of select cargo proteins, notably fibroblast growth factor 21 (FGF21), by acting as a cargo receptor that facilitates FGF21 sorting into COPII vesicles. In mouse models, YIPF6 mutations cause spontaneous intestinal inflammation and sensitivity to colitis, and in the liver, loss of YIPF6 leads to increased FGF21 secretion, protecting against diet-induced obesity and hepatic steatosis. YIPF6 therefore plays a critical role in membrane trafficking, protein secretion, and metabolic and inflammatory disease, making it a candidate therapeutic target in these contexts.
YIPF6 acts as a cargo receptor for the packaging and selective secretion of FGF21 via COPII vesicles; modulation of its function could indirectly affect FGF21 levels, an established therapeutic axis in metabolic diseases
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Yip1 domain family member 6 (YIPF6).